Clarksville, MD, United States of America

Yongjun Guan


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Abingdon, MD (US) (2014)
  • Clarksville, MD (US) (2018 - 2021)

Company Filing History:


Years Active: 2014-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yongjun Guan: Innovator in Antibody-Based Therapeutics

Introduction

Yongjun Guan is a prominent inventor based in Clarksville, MD (US). He has made significant contributions to the field of antibody-based therapeutics, holding a total of 3 patents. His work focuses on developing innovative solutions for treating infections, particularly those caused by toxins.

Latest Patents

Guan's latest patents include groundbreaking inventions such as tetra-specific, octameric binding agents and antibodies against toxin A and toxin B for the treatment of infections. These novel, antibody-based binding agents are derived from human and camelid immunoglobulins. They are designed to recognize and bind with specificity to toxin A and/or toxin B, exhibiting toxin-neutralizing activity. This technology has the potential to treat or prevent primary and recurrent Clostridium difficile infections (CDI). Additionally, he has developed recombinant fusion proteins comprising HIV gp120 linked to an enhancing CD4 binding site monoclonal antibody. These fusion proteins may serve in immunogenic formulations for vaccination against HIV-1 infection and include methods for generating an immune response.

Career Highlights

Yongjun Guan is affiliated with the University System of Maryland, where he continues to advance his research and innovation in the field of immunology. His work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

Guan collaborates with notable colleagues, including George K Lewis and Anthony DeVico, who contribute to his research endeavors and enhance the scope of his projects.

Conclusion

Yongjun Guan is a distinguished inventor whose work in antibody-based therapeutics is paving the way for new treatment options for serious infections. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…